Sensei Biotherapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €9.37M +∞% -€31.98M -26.8% -341.2% -3.4 pp N/A N/A
    (estimated) N/A -€43.66M +25.2% N/A N/A N/A
    (estimated) €0.00 +NaN% -€34.88M +18.0% N/A N/A N/A
    (estimated) €0.00 +NaN% -€29.56M +20.0% N/A N/A N/A
    (estimated) €0.00 +NaN% -€24.63M -5.2% N/A N/A N/A
    €0.00 +NaN% -€25.98M -11.6% N/A -€21.13M -23.0% N/A
    €0.00 +NaN% -€29.38M -30.1% N/A -€27.43M -17.7% N/A
    €0.00 +NaN% -€42.05M +30.3% N/A -€33.35M +37.1% N/A
    €0.00 +NaN% -€32.28M +81.6% N/A -€24.32M +71.1% N/A
    €0.00 +NaN% -€17.77M +8.6% N/A -€14.21M +93.7% N/A
    €0.00 +NaN% -€16.37M +45.7% N/A -€7.34M -17.2% N/A
    €0.00 -€11.23M N/A -€8.86M N/A

    Notifications